Strs Ohio Trims Stock Holdings in HealthEquity, Inc. $HQY

Strs Ohio decreased its position in HealthEquity, Inc. (NASDAQ:HQY) by 48.4% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 33,200 shares of the company’s stock after selling 31,200 shares during the quarter. Strs Ohio’s holdings in HealthEquity were worth $2,775,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in HQY. Fifth Third Wealth Advisors LLC boosted its holdings in shares of HealthEquity by 4.2% during the 1st quarter. Fifth Third Wealth Advisors LLC now owns 2,872 shares of the company’s stock valued at $240,000 after buying an additional 116 shares in the last quarter. Truist Financial Corp grew its position in shares of HealthEquity by 4.9% in the 4th quarter. Truist Financial Corp now owns 2,537 shares of the company’s stock worth $232,000 after buying an additional 119 shares during the period. Fiduciary Trust Co increased its stake in shares of HealthEquity by 3.4% in the 3rd quarter. Fiduciary Trust Co now owns 3,669 shares of the company’s stock worth $348,000 after acquiring an additional 120 shares in the last quarter. Larson Financial Group LLC lifted its position in HealthEquity by 24.4% during the 3rd quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock valued at $60,000 after acquiring an additional 123 shares during the period. Finally, GAMMA Investing LLC lifted its position in HealthEquity by 9.5% during the 4th quarter. GAMMA Investing LLC now owns 1,944 shares of the company’s stock valued at $178,000 after acquiring an additional 168 shares during the period. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Analyst Ratings Changes

HQY has been the topic of several research reports. Citizens Jmp boosted their price objective on shares of HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a research note on Monday, June 1st. Weiss Ratings raised shares of HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, June 5th. JPMorgan Chase & Co. lowered their target price on shares of HealthEquity from $129.00 to $123.00 and set an “overweight” rating for the company in a report on Wednesday, March 18th. Royal Bank Of Canada boosted their price target on HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a research report on Wednesday, June 3rd. Finally, Barrington Research restated an “outperform” rating and issued a $110.00 price target on shares of HealthEquity in a research note on Friday, May 22nd. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $110.57.

HealthEquity Stock Up 0.1%

Shares of HQY traded up $0.07 during trading hours on Tuesday, hitting $96.64. The company had a trading volume of 30,214 shares, compared to its average volume of 1,009,330. The stock has a market capitalization of $8.08 billion, a price-to-earnings ratio of 36.19, a P/E/G ratio of 1.60 and a beta of 0.21. The firm has a fifty day moving average price of $86.41 and a 200-day moving average price of $84.60. HealthEquity, Inc. has a 52-week low of $72.76 and a 52-week high of $105.96. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. The business had revenue of $354.64 million during the quarter, compared to analyst estimates of $352.02 million. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The firm’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, equities research analysts forecast that HealthEquity, Inc. will post 3.92 EPS for the current fiscal year.

Insider Activity

In related news, Director Gayle Furgurson Wellborn sold 2,439 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $219,510.00. Following the completion of the sale, the director owned 19,733 shares of the company’s stock, valued at $1,775,970. This trade represents a 11.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 3,142 shares of the business’s stock in a transaction that occurred on Friday, May 29th. The stock was sold at an average price of $95.00, for a total transaction of $298,490.00. Following the completion of the transaction, the executive vice president owned 59,113 shares of the company’s stock, valued at approximately $5,615,735. The trade was a 5.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 13,081 shares of company stock worth $1,193,000 over the last 90 days. 1.60% of the stock is currently owned by insiders.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.